Older individuals and, in particular, individuals at risk of recurrent stroke, may be susceptible to thrombosis when participating in exercise, however, this aspect has not been well investigated. The aim of this study is to evaluate the effects of a single bout of graded moderate intensity cycling exercise on incipient clot microstructure, and plasma clotting biomarkers, in lacunar stroke patients and in healthy age-matched controls.
Featured Article: Exercise transiently increases the density of incipient blood clots in antiplatelet-treated lacunar stroke patients
Articles
-
-
Association of initial national early warning score with clinical deterioration in pulmonary embolism
-
A retrospective cohort analysis of plasma TAT level trends and adverse pregnancy outcomes in early pregnancy patients with newly diagnosed VTE
-
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes
-
D-dimer to fibrinogen ratio as a marker for acute cerebral venous thrombosis
-
Heparin-induced thrombocytopenia: an update
-
Laboratory assessment of rivaroxaban: a review
-
Practical management of patients on apixaban: a consensus guide
-
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
-
Hereditary thrombophilia
Recommended reading
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, Pimjai Niparuck & Pantep Angchaisuksiri
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia
Xueya Zhang & Xizhe Guo
Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer
Nadia I Abelhad, Wei Qiao, Naveen Garg &
Cristhiam M. Rojas-Hernandez
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort
Mark M. G. Mulder, LIoyd Brandts, Renée A. G. Brüggemann, Marcel Koelmann, Alexander S. Streng, Renske H. Olie, Hester A. Gietema, Henri M. H. Spronk, Iwan C. C. van der Horst, Jan-Willem E. M. Sels, Joachim E. Wildberger, Sander M. J. van Kuijk, Ronny M. Schnabel, Hugo ten Cate, Yvonne M. C. Henskens & Bas C. T. van Bussel
Thiol-based Redox Regulation of Thrombosis
Edited by:
Yi Wu, MD, PhD, Soochow University, China
Submission Status: Open until 15 June 2025
Trending articles
Click here to view the most shared articles in the last month!
Aims and scope
Thrombosis Journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis.
Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline
Asian-Pacific Society on Thrombosis and Hemostasis
The Asian-Pacific Society of Thrombosis and Hemostasis (APSTH) is a non-profit organization that welcomes any medical or scientific professionals with an interest in the field of thrombosis and hemostasis, particularly those professionals from the Asia Pacific Region.
The main objectives of APSTH are to foster and advance clinical and scientific knowledge in the field of thrombosis, hemostasis and vascular biology through promotion of scientific exchange via meetings, publications, and promotion of international cooperation in clinical studies, and standardization of nomenclature and practices in the Asia-Pacific region.
Official journal of
-
Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.6
5-year Journal Impact Factor: 3.1
Source Normalized Impact per Paper (SNIP): 0.653
SCImago Journal Rank (SJR): 0.572Speed 2024
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 108Usage 2024
Downloads: 622,602
Altmetric mentions: 627